|
US2013245385A1
|
|
Selective anti-hla antibody removal device and methods of production and use thereof
|
|
US2013131573A1
|
|
Selective anti-hla antibody removal device and methods of production and use thereof
|
|
US2009062512A1
|
|
Comparative ligand mapping from MHC class I positive cells
|
|
US2008145872A1
|
|
Expression of HLA proteins on non human cells
|
|
US2009182131A1
|
|
Methods for removing anti-MHC antibodies from a sample
|
|
US2007099182A1
|
|
Comparative ligand mapping from MHC class I positive cells
|
|
WO2007053644A2
|
|
Comparative ligand mapping from mhc class i positive cells
|
|
US2007026433A1
|
|
Epitope testing using soluble HLA
|
|
US2006034865A1
|
|
Soluble MHC artificial antigen presenting cells
|
|
US2006276629A9
|
|
Purification and characterization of soluble human HLA proteins
|
|
IL162845D0
|
|
Purification and characterization of hla proteins
|
|
WO03057852A2
|
|
Purification and characterization of hla proteins
|
|
WO02056908A2
|
|
Artificial antigen-presenting cells
|
|
WO02062846A2
|
|
Method and apparatus for the production of antigens and uses thereof
|
|
EP0986650A1
|
|
Class i sequence based typing of hla-a, -b, and -c alleles by direct dna sequencing
|
